Here's a snapshot of Sun Pharmaceutical's acquisitions and turnaround storiesExperts say there are three key tests — a substantial improvement opportunity, strategic fit for existing businesses and reasonable price.
Sun Pharma chief Dilip S Shanghvi expects Ranbaxy deal to be closed by mid-FebruaryDilip S Shanghvi expects the Ranbaxy deal to be concluded by middle of next month while stating that the key challenge before the combined ...
Is Sun Pharma founder Dilip Shanghvi readying a succession plan?Shanghvi, who recently steered the biggest acquisition in pharma sector by acquiring Ranbaxy, said in coming days he would like to focus on...
Life & times of Dr Anji Reddy and his brainchild Dr Reddy'sWhen a German trader asked Reddy if he could match boots’ quality, Reddy retorted he could, by adding some impurity.
Anji Reddy's absence not to change DRL's direction: AnalystsThe demise of Anji Reddy, the founder-chairman of pharma major Dr Reddy's Laboratories, is not expected to lead to major directional change...
Anji Reddy's absence not to change DRL's directionThe demise of Anji Reddy, the founder-chairman Dr Reddy's Laboratories, is not expected to lead to major directional changes, market analys...
Dr Reddy’s Laboratories founder Anji Reddy passes awayAnji Reddy, the pharmaceutical industry pioneer who helped establish India’s reputation as a supplier of inexpensive medicines to the world...
K Anji Reddy, promoter and chairman Dr Reddy's Lab, passes awaySatish Reddy, his son is currently Managing Director and CEO of the company, while son-in-law G V Prasad is the Vice Chairman and the Chief...
Dr Reddy's Laboratories' Anji Reddy skips AGM for first timeSpeculation on Dr Reddy's Laboratories' grand old founder Dr K Anji Reddy passing the baton to the senior management came alive at the comp...
- Growth rates may decline in next few years: Dr Reddy's Laboratories
Dr Reddy's Laboratories today said its growth rates are likely to decline in the next few years due to expiry of many of its patents.
- India and Russia will drive Dr Reddy’s growth : Dr K Anji Reddy
India and Russia will drive growth for Dr Reddy’s Laboratories in the coming years, Dr K Anji Reddy told shareholders.
- Unfinished Agenda: Kallam Anji Reddy sets lofty targets for philanthropy
Dr Reddy has set lofty targets for his philanthropy - like generating a million livelihoods by 2010 or providing safe drinking water to all...
- Dr Reddy's aim at $1 bn revenue per year in next 3 years
Pharma major Dr Reddy's Laboratories aims to earn revenue of $ 1 billion per year from branded generics for the next three years, said K. A...
- Dr Reddy's to restructure German subsi Betapharm
Pharma major Dr Reddy's Laboratories (DRL) on Friday said it was restructuring German subsidiary Betapharm for better results in the future.
- No plan to sell domestic formulations business: Dr Reddy's
Pharma major Dr Reddy's Laboratories Ltd (DRL) on Friday said it was restructuring German subsidiary Betapharm for better results in future...
- DRL promoters may hike holding
Drugmaker Dr Reddy’s Laboratories founder and chairman K Anji Reddy on Monday said he was looking at raising promoter holding in the compan...
- Championing a different cure
The medicine man from hyderabad is now targeting a killer disease - poverty.